[Not Available].
作者信息
Jones Nicholas R, Hobbs F D Richard, Taylor Clare J
机构信息
Boursier en formation clinique et universitaire au Département Nuffield des sciences de la santé de première ligne à l'Université d'Oxford, en Angleterre.
Chef de service au Département Nuffield des sciences de la santé de première ligne à l'Université d'Oxford, en Angleterre.
出版信息
Can Fam Physician. 2017 Dec;63(12):e510-e511.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
Can Fam Physician. 2017 Dec;63(12):e510-e511.
本文引用的文献
1
Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.英国全科医疗中预防药物的处方不足与中风和短暂性脑缺血发作的一级预防：一项回顾性分析
PLoS Med. 2016 Nov 15;13(11):e1002169. doi: 10.1371/journal.pmed.1002169. eCollection 2016 Nov.
2
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
3
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?新型抗凝药物是否优于华法林治疗房颤患者？
J Thorac Dis. 2015 Feb;7(2):165-71. doi: 10.3978/j.issn.2072-1439.2015.01.23.
4
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.优化心房颤动患者的卒中预防：GRASP-AF审核工具在英国全科医疗队列中的应用
Br J Gen Pract. 2015 Jan;65(630):e16-23. doi: 10.3399/bjgp15X683113.
5
Underuse of oral anticoagulants in atrial fibrillation: a systematic review.房颤患者中口服抗凝剂的使用率较低：一项系统评价。
Am J Med. 2010 Jul;123(7):638-645.e4. doi: 10.1016/j.amjmed.2009.11.025.
6
Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.非瓣膜性心房颤动患者使用抗凝治疗的障碍：澳大利亚家庭医生的代表性调查
Stroke. 2008 Jan;39(1):227-30. doi: 10.1161/STROKEAHA.107.495036. Epub 2007 Nov 29.
7
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.荟萃分析：抗栓治疗预防非瓣膜性心房颤动患者的卒中
Ann Intern Med. 2007 Jun 19;146(12):857-67. doi: 10.7326/0003-4819-146-12-200706190-00007.
8
'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation.经验法则还是反思性实践？理解老年医师关于心房颤动抗栓治疗用药的决策过程
QJM. 2007 May;100(5):263-9. doi: 10.1093/qjmed/hcm016. Epub 2007 Mar 27.
9
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.不良事件对心房颤动患者华法林处方的影响：配对分析
BMJ. 2006 Jan 21;332(7534):141-5. doi: 10.1136/bmj.38698.709572.55. Epub 2006 Jan 10.
10
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.为有跌倒风险的老年房颤患者选择抗栓治疗。
Arch Intern Med. 1999 Apr 12;159(7):677-85. doi: 10.1001/archinte.159.7.677.
Zotero 插件